Jingkao Chen

764 total citations
22 papers, 644 citations indexed

About

Jingkao Chen is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jingkao Chen has authored 22 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jingkao Chen's work include Alzheimer's disease research and treatments (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Nuclear Receptors and Signaling (3 papers). Jingkao Chen is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Nuclear Receptors and Signaling (3 papers). Jingkao Chen collaborates with scholars based in China, United States and Hong Kong. Jingkao Chen's co-authors include Rongbiao Pi, Qiuhe Chen, Yalin Tu, Guangmei Yan, Xiaohong Yang, Yifan Han, Shengnan Wang, Cheng Li, Wenbo Zhu and Minghua Jin and has published in prestigious journals such as Journal of Neuroscience, Brain Research and Journal of Medicinal Chemistry.

In The Last Decade

Jingkao Chen

21 papers receiving 640 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingkao Chen China 16 290 106 95 90 78 22 644
Pei-Chun Chang Taiwan 15 299 1.0× 85 0.8× 113 1.2× 50 0.6× 89 1.1× 30 601
Qiong Cheng China 18 397 1.4× 94 0.9× 94 1.0× 68 0.8× 77 1.0× 38 679
Peng Zeng China 20 330 1.1× 172 1.6× 109 1.1× 65 0.7× 85 1.1× 59 899
Min-Ju Kim South Korea 18 286 1.0× 137 1.3× 74 0.8× 41 0.5× 67 0.9× 46 670
Rabab H. Sayed Egypt 19 308 1.1× 99 0.9× 105 1.1× 48 0.5× 78 1.0× 54 828
Yalin Tu China 11 248 0.9× 89 0.8× 79 0.8× 53 0.6× 74 0.9× 18 505
Nan Feng China 18 261 0.9× 95 0.9× 136 1.4× 54 0.6× 87 1.1× 39 660
Yue Jia China 17 432 1.5× 56 0.5× 72 0.8× 81 0.9× 112 1.4× 28 752
Ayman E. El-Sahar Egypt 19 260 0.9× 76 0.7× 87 0.9× 47 0.5× 93 1.2× 36 793
Pedro A. Dionísio Portugal 12 412 1.4× 150 1.4× 103 1.1× 114 1.3× 38 0.5× 13 722

Countries citing papers authored by Jingkao Chen

Since Specialization
Citations

This map shows the geographic impact of Jingkao Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingkao Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingkao Chen more than expected).

Fields of papers citing papers by Jingkao Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingkao Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingkao Chen. The network helps show where Jingkao Chen may publish in the future.

Co-authorship network of co-authors of Jingkao Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Jingkao Chen. A scholar is included among the top collaborators of Jingkao Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingkao Chen. Jingkao Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Cheng, et al.. (2025). A novel derivative of rhein overcomes temozolomide resistance in glioblastoma by regulating SOX9 through m6A methylation. Brain Research. 1866. 149889–149889. 1 indexed citations
2.
Zhang, Bei, Yukang Lin, Ting Wang, et al.. (2025). Structure-Guided Discovery of Novel N4-(Substituted Thiazol-2-yl)-N2-(4-Substituted phenyl)pyrimidine-2,4-Diamines as Potent CDK2 and CDK9 Dual Inhibitors with High Oral Bioavailability. Journal of Medicinal Chemistry. 68(2). 1693–1715. 4 indexed citations
3.
Wang, Ting, Xuanxuan Ma, Rou Li, et al.. (2024). Design, concise synthesis and evaluation of novel amide-based combretastatin A-4 analogues as potent tubulin inhibitors. Bioorganic & Medicinal Chemistry Letters. 108. 129816–129816.
4.
Li, Cheng, Qiuhe Chen, Rongbiao Pi, & Jingkao Chen. (2021). A research update on the therapeutic potential of rhein and its derivatives. European Journal of Pharmacology. 899. 173908–173908. 58 indexed citations
5.
Chen, Qiuhe, Yalin Tu, Shinghung Mak, et al.. (2020). Discovery of a novel small molecule PT109 with multi-targeted effects against Alzheimer's disease in vitro and in vivo. European Journal of Pharmacology. 883. 173361–173361. 9 indexed citations
6.
Chen, Jingkao, Bingling Luo, Shijun Wen, & Rongbiao Pi. (2019). Discovery of a novel rhein-SAHA hybrid as a multi-targeted anti-glioblastoma drug. Investigational New Drugs. 38(3). 755–764. 21 indexed citations
7.
Jiang, Yiming, Minghua Jin, Jingkao Chen, et al.. (2019). Discovery of a novel niacin-lipoic acid dimer N2L attenuating atherosclerosis and dyslipidemia with non-flushing effects. European Journal of Pharmacology. 868. 172871–172871. 9 indexed citations
8.
Li, Kaishu, Yalin Tu, Qingyu Liu, et al.. (2017). PT93, a novel caffeic acid amide derivative, suppresses glioblastoma cells migration, proliferation and MMP-2/−9 expression. Oncology Letters. 13(3). 1990–1996. 8 indexed citations
9.
Chen, Jingkao, Zhaowei Sun, Minghua Jin, et al.. (2017). Inhibition of AGEs/RAGE/Rho/ROCK pathway suppresses non-specific neuroinflammation by regulating BV2 microglial M1/M2 polarization through the NF-κB pathway. Journal of Neuroimmunology. 305. 108–114. 108 indexed citations
10.
11.
Chen, Jingkao, Wei Yin, Yalin Tu, et al.. (2017). L-F001, a novel multifunctional ROCK inhibitor, suppresses neuroinflammation in vitro and in vivo: Involvement of NF-κB inhibition and Nrf2 pathway activation. European Journal of Pharmacology. 806. 1–9. 47 indexed citations
12.
Chen, Ziwei, Maria Digiacomo, Yalin Tu, et al.. (2016). Discovery of novel rivastigmine-hydroxycinnamic acid hybrids as multi-targeted agents for Alzheimer's disease. European Journal of Medicinal Chemistry. 125. 784–792. 59 indexed citations
13.
He, Ming‐Liang, Ming Luo, Qingyu Liu, et al.. (2016). Combination treatment with fasudil and clioquinol produces synergistic anti-tumor effects in U87 glioblastoma cells by activating apoptosis and autophagy. Journal of Neuro-Oncology. 127(2). 261–270. 17 indexed citations
14.
Chu, Jiaqi, et al.. (2015). Effects of melatonin and its analogues on neural stem cells. Molecular and Cellular Endocrinology. 420. 169–179. 43 indexed citations
15.
Hu, Haiyan, Yuehan Zhou, Tiandong Leng, et al.. (2014). The Major Cholesterol Metabolite Cholestane-3β,5α,6β-Triol Functions as an Endogenous Neuroprotectant. Journal of Neuroscience. 34(34). 11426–11438. 37 indexed citations
16.
Chen, Jingkao, Ying Ouyang, Lin Cao, et al.. (2013). Diazepam Inhibits Proliferation of Human Glioblastoma Cells Through Triggering a G0/G1 Cell Cycle Arrest. Journal of Neurosurgical Anesthesiology. 25(3). 285–291. 15 indexed citations
17.
Li, Yuan, Jingkao Chen, Sihan Wu, et al.. (2013). Inhibition of cancer cell proliferation by midazolam by targeting transient receptor potential melastatin 7. Oncology Letters. 5(3). 1010–1016. 28 indexed citations
18.
Yang, Xiaoxiao, Shifeng Li, Wande Li, et al.. (2012). Inactivation of lysyl oxidase by β-aminopropionitrile inhibits hypoxia-induced invasion and migration of cervical cancer cells. Oncology Reports. 29(2). 541–548. 49 indexed citations
19.
Zhang, Haipeng, Wenbo Zhu, Xingwen Su, et al.. (2012). Triptolide inhibits proliferation and invasion of malignant glioma cells. Journal of Neuro-Oncology. 109(1). 53–62. 28 indexed citations
20.
Shu, Minfeng, Yuehan Zhou, Wenbo Zhu, et al.. (2011). MicroRNA 335 Is Required for Differentiation of Malignant Glioma Cells Induced by Activation of cAMP/Protein Kinase A Pathway. Molecular Pharmacology. 81(3). 292–298. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pei-Chun Chang Breakdown of academic impact, for papers by Qiong Cheng Breakdown of academic impact, for papers by Peng Zeng Breakdown of academic impact, for papers by Min-Ju Kim Breakdown of academic impact, for papers by Rabab H. Sayed Breakdown of academic impact, for papers by Yalin Tu Breakdown of academic impact, for papers by Nan Feng Breakdown of academic impact, for papers by Yue Jia Breakdown of academic impact, for papers by Ayman E. El-Sahar Breakdown of academic impact, for papers by Pedro A. Dionísio
Rankless by CCL
2026